Medical Devices Late Stage Investors & VC Firms
247 firms in this list, with a median first check of $1.1M. 58 of them lead rounds. Generated from verified public data and updated continuously.
Healthcare Venture Partners, Llc
CharlestonSeries B–Late Stage
10 people
KIC Ventures
Fort LauderdaleGrowth–Late Stage
10 people
Claremont Creek Ventures
OaklandSeed–Late Stage$500K – $3M
5 people
Vesalius Biocapital III Partners SàRL
ConternSeries B–Late Stage$10.8M
11 people
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
7 people
Seido Capital
BrusselsPre-Seed–Late Stage$270K – $2.7M
7 people
Birch Venture Capital, Inc.
Taipei CitySeed–Late Stage
3 people
Aurum Ventures MKI
Ramat GanSeed–Late Stage
8 people
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
3 people
Brace Pharma
AtlantaLate Stage
5 people
Mayo Clinic Ventures
RochesterSeed–Late Stage
2 people
DFJ DragonFund
ShanghaiSeed–Late Stage
Vision Creator
SeoulSeed–Late Stage
BSK Investment
SeoulSeed–Late Stage
14 people
Axil Capital
TokyoSeed–Late Stage
7 people
ACORN BIOVENTURES
New YorkSeed–Late Stage
3 people
Centurium Capital
XiamenGrowth–Late Stage
3 people
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
8 people
Fletcher Spaght, Inc.
BostonLate Stage
8 people
Flying L Partners
Series A–Late Stage
5 people
Powerhouse Ventures
Fortitude ValleyGrowth–Late Stage
8 people
Soleus Capital
GreenwichLate Stage
2 people
Roadmap Capital Inc.
TorontoSeed–Late Stage
5 people
venture / science
San FranciscoSeed–Late Stage
2 people
Related lists
Medical Devices Investors & VC Firms (1714)Late Stage Investors & VC Firms (1710)Medical Devices Seed Investors & VC Firms (1369)Medical Devices Series A Investors & VC Firms (1174)Medical Devices Investors & VC Firms in North America (1135)Medical Devices Investors & VC Firms in United States (1053)Late Stage Investors & VC Firms in North America (915)Late Stage Investors & VC Firms in United States (814)Medical Devices Investors & VC Firms in Europe (687)Late Stage Investors & VC Firms in Global (566)
Data sourced from public filings and firms' own websites — see our methodology.


















































